Physician profile
Rohit Beri
NPI 1881892784
$1,985.58
in general payments reported to CMS, 2019-2025
22 companies · $433 in 2025
The $433 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $154 · 2022: $56.05 · 2023: $238 · 2024: $413 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $907.57 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.97 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $101.32 | 2019 | |
| Zoll Respicardia, INC. | $93.89 | 2024 | Remede System |
| Insmed, INC. | $90.69 | 2019-2025 | Arikayce |
| Shire North American Group INC | $83.43 | 2019 | |
| Inspire Medical Systems, INC. | $74.40 | 2025 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $67.36 | 2023-2024 | Glassia |
| Amgen INC. | $63.56 | 2023-2025 | Tezspire |
| Circassia INC. | $51.13 | 2019-2020 | |
| Genzyme Corporation | $49.05 | 2019 | |
| Jazz Pharmaceuticals INC. | $35.75 | 2019-2020 | |
| Verona Pharma, INC. | $32.89 | 2025 | Ohtuvayre |
| 3b Medical, INC. | $29.93 | 2025 | Luna |
| Baxter Healthcare | $26.20 | 2023 | Hillrom - Life 2000 Ventilation System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ceribell, INC. | $24.92 | 2025 | Pocket Eeg Device |
| Mylan Specialty L.P. | $22.65 | 2024 | Yupelri |
| Grifols USA, LLC | $20.45 | 2019 | |
| Philips North America LLC | $18.79 | 2020 | |
| Pulmonx Corporation | $17.43 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $17.34 | 2019 | |
| Lilly USA, LLC | $16.86 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Beri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.